Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Infusion reaction to inflixima...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Infusion reaction to infliximab biosimilar after transitioning from infliximab

Infusion reaction to infliximab biosimilar after transitioning from infliximab

Bibliographic Details
Main Authors: Reem Kashlan, MPH, Alexis B. Lyons, MD, Shanthi Narla, MD, Iltefat H. Hamzavi, MD
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:JAAD Case Reports
Subjects:
biosimilar
hidradenitis suppurativa
infliximab
infusion reaction
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512620308584
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352512620308584

Similar Items

  • Serum infliximab levels and clinical response in hidradenitis suppurativa
    by: Erwin Benassaia, et al.
    Published: (2023-06-01)
  • The Efficacy and Safety of Biosimilars in Hidradenitis Suppurativa: A Comprehensive Review
    by: Almukhadeb E, et al.
    Published: (2024-08-01)
  • Adherence patterns in naïve and prevalent use of infliximab and its biosimilar
    by: Chibuike J. Alanaeme, et al.
    Published: (2022-11-01)
  • Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
    by: Bas J. M. Peters, et al.
    Published: (2021-02-01)
  • Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
    by: Fitzgerald T, et al.
    Published: (2021-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs